Alexandru Eniu
- Oncology top 1%
- Cancer Research top 1%
- Radiology, Nuclear Medicine and Imaging top 2%
- Economics and Econometrics top 2%
- Pulmonary and Respiratory Medicine top 5%
- Co-authors
- Robert W. CarlsonBenjamin O. AndersonJavier CortésTamas HickishAndreas SchneeweißStephen ChiaCheng Har YipRobert A. Smith
- Topics
- Economic and Financial Impacts of Cancer (22 papers)HER2/EGFR in Cancer Research (20 papers)Cancer Treatment and Pharmacology (18 papers)
- Partner nations
- RomaniaUnited StatesUnited Kingdom
In The Last Decade
Alexandru Eniu
70 papers receiving 3.6k citations
Hit Papers
Peers
Comparison fields: 5 of 125
- Oncology 2.6k
- Cancer Research 1.1k
- Radiology, Nuclear Medicine and Imaging 725
- Economics and Econometrics 581
- Pulmonary and Respiratory Medicine 469
Countries citing papers authored by Alexandru Eniu
This map shows the geographic impact of Alexandru Eniu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexandru Eniu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexandru Eniu more than expected).
Fields of papers citing papers by Alexandru Eniu
This network shows the impact of papers produced by Alexandru Eniu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexandru Eniu. The network helps show where Alexandru Eniu may publish in the future.
Co-authorship network of co-authors of Alexandru Eniu
This figure shows the co-authorship network connecting the top 25 collaborators of Alexandru Eniu. A scholar is included among the top collaborators of Alexandru Eniu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexandru Eniu. Alexandru Eniu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 7 | |
| 5 | 12 | |
| 6 | 7 | |
| 7 | 11 | |
| 8 | 25 | |
| 9 | 42 | |
| 10 | 5 | |
| 11 | 84 | |
| 12 | 88 | |
| 13 | 71 | |
| 14 | 24 | |
| 15 | 42 | |
| 16 | 167 | |
| 17 | 75 | |
| 18 | 90 | |
| 19 | Integrating biological agents into systemic therapy of breast cancer: trastuzumab, lapatinib, bevacizumab. | 9 |
| 20 | 60 |
About Alexandru Eniu
Alexandru Eniu is a scholar working on Oncology, Cancer Research and Radiology, Nuclear Medicine and Imaging, having authored 74 papers that have together received 3.7k indexed citations. Recurring topics across this work include Economic and Financial Impacts of Cancer (22 papers), HER2/EGFR in Cancer Research (20 papers) and Cancer Treatment and Pharmacology (18 papers). The work is most often cited by research in Oncology (2.6k citations), Cancer Research (1.1k citations) and Radiology, Nuclear Medicine and Imaging (725 citations). Alexandru Eniu has collaborated with scholars based in Romania, United States and United Kingdom. Frequent co-authors include Robert W. Carlson, Benjamin O. Anderson, Javier Cortés, Tamas Hickish, Andreas Schneeweiß, Stephen Chia, Cheng Har Yip, Robert A. Smith, Roman Shyyan and Virginia McNally. Their work appears in journals such as The Lancet, Journal of Clinical Oncology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.